As ADM concentrations reach nanomolar levels or higher, there is an upregulation in the expression of angiogenic factors such as the vascular endothelial growth factor (VEGF), monocyte chemoattractant protein-1 (MCP-1), and basic fibroblast growth factor (bFGF) within the MC/tumor complex. Here, ADM is linked to neoplasm.